ArticleCancers2024

Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.

Koji Mita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.